{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:06:45Z","timestamp":1787771205302,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education, Youth and Sports of the Czech Republic","award":["National Sustainability Program I [LO1503]"],"award-info":[{"award-number":["National Sustainability Program I [LO1503]"]}]},{"name":"Charles University, Prague, Czech Republic","award":["Progres Q39"],"award-info":[{"award-number":["Progres Q39"]}]},{"name":"Institute for Clinical and Experimental Medicine, Prague, Czech Republic","award":["MZO 00023001"],"award-info":[{"award-number":["MZO 00023001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3493-y","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T12:46:21Z","timestamp":1542285981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-598X","authenticated-orcid":false,"given":"Tomas","family":"Reischig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kacer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Hruba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Hermanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Hes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lysak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Kormunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Bouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"issue":"4","key":"3493_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ajt.14208","volume":"17","author":"JA Fishman","year":"2017","unstructured":"Fishman JA. Infection in organ transplantation. Am J Transplant. 2017;17(4):856\u201379.","journal-title":"Am J Transplant"},{"issue":"4","key":"3493_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","volume":"96","author":"CN Kotton","year":"2013","unstructured":"Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, Humar A. Transplantation society international CMVCG: updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96(4):333\u201360.","journal-title":"Transplantation"},{"issue":"1","key":"3493_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","volume":"66","author":"S Sagedal","year":"2004","unstructured":"Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degre M, Fauchald P, Rollag H. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int. 2004;66(1):329\u201337.","journal-title":"Kidney Int"},{"issue":"6","key":"3493_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3851\/IMP3129","volume":"22","author":"T Reischig","year":"2017","unstructured":"Reischig T, Kacer M, Hruba P, Jindra P, Hes O, Lysak D, Bouda M, Viklicky O. The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation. Antivir Ther. 2017;22(6):503\u201313.","journal-title":"Antivir Ther"},{"issue":"8","key":"3493_CR5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/tri.12972","volume":"30","author":"WT Lollinga","year":"2017","unstructured":"Lollinga WT, Rurenga-Gard L, van Doesum W, van Bergen R, Diepstra A, Vonk JM, Riezebos-Brilman A, Niesters HGM, van Son WJ, van den Born J, et al. High human cytomegalovirus DNAemia early post-transplantation associates with irreversible and progressive loss of renal function - a retrospective study. Transpl Int. 2017;30(8):817\u201326.","journal-title":"Transpl Int"},{"issue":"8","key":"3493_CR6","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1111\/ajt.13791","volume":"16","author":"H Kaminski","year":"2016","unstructured":"Kaminski H, Fishman JA. The cell biology of cytomegalovirus: implications for transplantation. Am J Transplant. 2016;16(8):2254\u201369.","journal-title":"Am J Transplant"},{"issue":"10","key":"3493_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/cid\/cir619","volume":"53","author":"M Dzabic","year":"2011","unstructured":"Dzabic M, Rahbar A, Yaiw KC, Naghibi M, Religa P, Fellstrom B, Larsson E, Soderberg-Naucler C. Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival. Clin Infect Dis. 2011;53(10):969\u201376.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"3493_CR8","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1681\/ASN.2013101052","volume":"25","author":"T Bachelet","year":"2014","unstructured":"Bachelet T, Couzi L, Pitard V, Sicard X, Rigothier C, Lepreux S, Moreau JF, Taupin JL, Merville P, Dechanet-Merville J. Cytomegalovirus-responsive gammadelta T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions. J Am Soc Nephrol. 2014;25(11):2471\u201382.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3493_CR9","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/ajt.13618","volume":"16","author":"KM Heutinck","year":"2016","unstructured":"Heutinck KM, Yong SL, Tonneijck L, van den Heuvel H, van der Weerd NC, van der Pant KA, Bemelman FJ, Claas FH, Ten Berge IJ. Virus-specific CD8(+) T cells cross-reactive to donor-alloantigen are transiently present in the circulation of kidney transplant recipients infected with CMV and\/or EBV. Am J Transplant. 2016;16(5):1480\u201391.","journal-title":"Am J Transplant"},{"issue":"2","key":"3493_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jcv.2006.01.015","volume":"36","author":"T Reischig","year":"2006","unstructured":"Reischig T, Jindra P, Svecova M, Kormunda S, Opatrny K Jr, Treska V. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection. J Clin Virol. 2006;36(2):146\u201351.","journal-title":"J Clin Virol"},{"issue":"10","key":"3493_CR11","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/infdis\/jit064","volume":"207","author":"C Courivaud","year":"2013","unstructured":"Courivaud C, Bamoulid J, Chalopin JM, Gaiffe E, Tiberghien P, Saas P, Ducloux D. Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients. J Infect Dis. 2013;207(10):1569\u201375.","journal-title":"J Infect Dis"},{"issue":"9","key":"3493_CR12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1007\/s00125-004-1499-z","volume":"47","author":"J Hjelmesaeth","year":"2004","unstructured":"Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia. 2004;47(9):1550\u20136.","journal-title":"Diabetologia"},{"issue":"9","key":"3493_CR13","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1432-2277.2012.01521.x","volume":"25","author":"C Courivaud","year":"2012","unstructured":"Courivaud C, Bamoulid J, Gaugler B, Roubiou C, Arregui C, Chalopin JM, Borg C, Tiberghien P, Woronoff-Lemsi MC, Saas P, et al. Cytomegalovirus exposure, immune exhaustion and cancer occurrence in renal transplant recipients. Transpl Int. 2012;25(9):948\u201355.","journal-title":"Transpl Int"},{"issue":"4","key":"3493_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/TP.0000000000001608","volume":"101","author":"T Vanhove","year":"2017","unstructured":"Vanhove T, Goldschmeding R, Kuypers D. Kidney fibrosis: origins and interventions. Transplantation. 2017;101(4):713\u201326.","journal-title":"Transplantation"},{"issue":"3","key":"3493_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.kint.2017.03.033","volume":"92","author":"C Gosset","year":"2017","unstructured":"Gosset C, Viglietti D, Rabant M, Verine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, et al. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. Kidney Int. 2017;92(3):729\u201342.","journal-title":"Kidney Int"},{"issue":"1","key":"3493_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/ajt.13423","volume":"16","author":"FG Cosio","year":"2016","unstructured":"Cosio FG, El Ters M, Cornell LD, Schinstock CA, Stegall MD. Changing kidney allograft histology early Posttransplant: prognostic implications of 1-year protocol biopsies. Am J Transplant. 2016;16(1):194\u2013203.","journal-title":"Am J Transplant"},{"issue":"6","key":"3493_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1432-2277.2005.00113.x","volume":"18","author":"K Inkinen","year":"2005","unstructured":"Inkinen K, Soots A, Krogerus L, Loginov R, Bruggeman C, Lautenschlager I. Cytomegalovirus enhance expression of growth factors during the development of chronic allograft nephropathy in rats. Transpl Int. 2005;18(6):743\u20139.","journal-title":"Transpl Int"},{"issue":"3","key":"3493_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/TP.0b013e318192ded5","volume":"87","author":"T Reischig","year":"2009","unstructured":"Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Transplantation. 2009;87(3):436\u201344.","journal-title":"Transplantation"},{"issue":"9","key":"3493_CR19","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1681\/ASN.2009111188","volume":"21","author":"JM Smith","year":"2010","unstructured":"Smith JM, Corey L, Bittner R, Finn LS, Healey PJ, Davis CL, McDonald RA. Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation. J Am Soc Nephrol. 2010;21(9):1579\u201386.","journal-title":"J Am Soc Nephrol"},{"key":"3493_CR20","volume":"2","author":"EM Hodson","year":"2013","unstructured":"Hodson EM, Ladhani M, Webster AC, Strippoli GF, Craig JC. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. The Cochrane database of systematic reviews. 2013;2:CD003774.","journal-title":"The Cochrane database of systematic reviews"},{"issue":"5","key":"3493_CR21","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","volume":"10","author":"A Humar","year":"2010","unstructured":"Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant. 2010;10(5):1228\u201337.","journal-title":"Am J Transplant"},{"issue":"3","key":"3493_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/01.TP.0000150024.01672.CA","volume":"79","author":"T Reischig","year":"2005","unstructured":"Reischig T, Jindra P, Mares J, Cechura M, Svecova M, Hes O, Opatrny K Jr, Treska V. Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection. Transplantation. 2005;79(3):317\u201324.","journal-title":"Transplantation"},{"issue":"19","key":"3493_CR23","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","volume":"340","author":"D Lowance","year":"1999","unstructured":"Lowance D, Neumayer HH, Legendre CM, Squifflet JP, Kovarik J, Brennan PJ, Norman D, Mendez R, Keating MR, Coggon GL, et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir cytomegalovirus prophylaxis transplantation study group. N Engl J Med. 1999;340(19):1462\u201370.","journal-title":"N Engl J Med"},{"issue":"1","key":"3493_CR24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2007.02031.x","volume":"8","author":"T Reischig","year":"2008","unstructured":"Reischig T, Jindra P, Hes O, Svecova M, Klaboch J, Treska V. Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. Am J Transplant. 2008;8(1):69\u201377.","journal-title":"Am J Transplant"},{"issue":"9","key":"3493_CR25","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1681\/ASN.2012010100","volume":"23","author":"T Reischig","year":"2012","unstructured":"Reischig T, Hribova P, Jindra P, Hes O, Bouda M, Treska V, Viklicky O. Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. J Am Soc Nephrol. 2012;23(9):1588\u201397.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3493_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2215\/CJN.07020714","volume":"10","author":"T Reischig","year":"2015","unstructured":"Reischig T, Kacer M, Jindra P, Hes O, Lysak D, Bouda M. Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. Clinical journal of the American Society of Nephrology : CJASN. 2015;10(2):294\u2013304.","journal-title":"Clinical journal of the American Society of Nephrology : CJASN"},{"issue":"2","key":"3493_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12590","volume":"14","author":"M Haas","year":"2014","unstructured":"Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14(2):272\u201383.","journal-title":"Am J Transplant"},{"issue":"4","key":"3493_CR28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1600-6143.2010.03312.x","volume":"11","author":"MD Stegall","year":"2011","unstructured":"Stegall MD, Park WD, Larson TS, Gloor JM, Cornell LD, Sethi S, Dean PG, Prieto M, Amer H, Textor S, et al. The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant. 2011;11(4):698\u2013707.","journal-title":"Am J Transplant"},{"issue":"9","key":"3493_CR29","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1111\/ajt.12370","volume":"13","author":"M El Ters","year":"2013","unstructured":"El Ters M, Grande JP, Keddis MT, Rodrigo E, Chopra B, Dean PG, Stegall MD, Cosio FG. Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am J Transplant. 2013;13(9):2334\u201341.","journal-title":"Am J Transplant"},{"issue":"6","key":"3493_CR30","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1097\/TP.0000000000001216","volume":"101","author":"C Garcia-Carro","year":"2017","unstructured":"Garcia-Carro C, Dorje C, Asberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisaeter AV. Inflammation in early kidney allograft surveillance biopsies with and without associated Tubulointerstitial chronic damage as a predictor of fibrosis progression and development of De novo donor specific antibodies. Transplantation. 2017;101(6):1410\u20135.","journal-title":"Transplantation"},{"issue":"7","key":"3493_CR31","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/ajt.13728","volume":"16","author":"BD Modena","year":"2016","unstructured":"Modena BD, Kurian SM, Gaber LW, Waalen J, Su AI, Gelbart T, Mondala TS, Head SR, Papp S, Heilman R, et al. Gene expression in biopsies of acute rejection and interstitial fibrosis\/tubular atrophy reveals highly shared mechanisms that correlate with worse long-term outcomes. Am J Transplant. 2016;16(7):1982\u201398.","journal-title":"Am J Transplant"},{"issue":"1","key":"3493_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/TP.0b013e3182782efc","volume":"95","author":"M Shimamura","year":"2013","unstructured":"Shimamura M, Seleme MC, Guo L, Saunders U, Schoeb TR, George JF, Britt WJ. Ganciclovir prophylaxis improves late murine cytomegalovirus-induced renal allograft damage. Transplantation. 2013;95(1):48\u201353.","journal-title":"Transplantation"},{"issue":"7","key":"3493_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.bbmt.2007.03.009","volume":"13","author":"M Battiwalla","year":"2007","unstructured":"Battiwalla M, Wu Y, Bajwa RP, Radovic M, Almyroudis NG, Segal BH, Wallace PK, Nakamura R, Padmanabhan S, Hahn T, et al. Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis. Biol Blood Marrow Transplant. 2007;13(7):765\u201370.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"3493_CR34","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3851\/IMP1879","volume":"16","author":"T Reischig","year":"2011","unstructured":"Reischig T, Prucha M, Sedlackova L, Lysak D, Jindra P, Bouda M, Matejovic M. Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients. Antivir Ther. 2011;16(8):1227\u201335.","journal-title":"Antivir Ther"},{"issue":"3","key":"3493_CR35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2215\/CJN.08420813","volume":"9","author":"N Elfadawy","year":"2014","unstructured":"Elfadawy N, Flechner SM, Schold JD, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation. Clinical journal of the American Society of Nephrology : CJASN. 2014;9(3):553\u201361.","journal-title":"Clinical journal of the American Society of Nephrology : CJASN"},{"issue":"4","key":"3493_CR36","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1681\/ASN.2014010119","volume":"26","author":"D Sawinski","year":"2015","unstructured":"Sawinski D, Forde KA, Trofe-Clark J, Patel P, Olivera B, Goral S, Bloom RD. Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies. J Am Soc Nephrol. 2015;26(4):966\u201375.","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"3493_CR37","first-page":"156","volume":"15","author":"O Gheith","year":"2017","unstructured":"Gheith O, Halim MA, Al-Otaibi T, Mansour H, Mosaad A, Atteya HA, Zakaria Z, Said T, Nair P, Nampoory N. Successful cost-effective prevention of cytomegalovirus disease in kidney transplant recipients using low-dose Valganciclovir. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 2017;15(Suppl 1):156\u201363.","journal-title":"Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation"},{"issue":"8","key":"3493_CR38","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1111\/ajt.13252","volume":"15","author":"T Schachtner","year":"2015","unstructured":"Schachtner T, Stein M, Babel N, Reinke P. The loss of BKV-specific immunity from Pretransplantation to Posttransplantation identifies kidney transplant recipients at increased risk of BKV replication. Am J Transplant. 2015;15(8):2159\u201369.","journal-title":"Am J Transplant"},{"issue":"6","key":"3493_CR39","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/ajt.12689","volume":"14","author":"T Schmidt","year":"2014","unstructured":"Schmidt T, Adam C, Hirsch HH, Janssen MW, Wolf M, Dirks J, Kardas P, Ahlenstiel-Grunow T, Pape L, Rohrer T, et al. BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication. Am J Transplant. 2014;14(6):1334\u201345.","journal-title":"Am J Transplant"},{"issue":"7203","key":"3493_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/bmj.319.7203.185","volume":"319","author":"C Roberts","year":"1999","unstructured":"Roberts C, Torgerson DJ. Understanding controlled trials: baseline imbalance in randomised controlled trials. BMJ. 1999;319(7203):185.","journal-title":"BMJ"},{"issue":"13","key":"3493_CR41","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","volume":"369","author":"FM Marty","year":"2013","unstructured":"Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Mommeja-Marin H, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2013;369(13):1227\u201336.","journal-title":"N Engl J Med"},{"issue":"25","key":"3493_CR42","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. 2017;377(25):2433\u201344.","journal-title":"N Engl J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3493-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3493-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3493-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T03:50:57Z","timestamp":1694058657000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3493-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3493"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3493-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]},"assertion":[{"value":"6 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Charles University Teaching Hospital Ethics Committee and conducted in compliance with the Declaration of Helsinki and Declaration of Istanbul. Written informed consent was obtained before enrollment. Trial registration: Australian New Zealand Clinical Trials Registry (ACTRN12610000016033)","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"573"}}